Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03471546 · ClinicalTrials.gov registry record · NA

Early Palliative Care Intervention in Malignant Glioma

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT03471546 is a NA study that has completed, run by Duke University. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03471546, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

The purpose of this research study is to determine the feasibility and acceptability of incorporating palliative care into the clinical care plans of patients newly diagnosed with malignant brain tumors. Palliative Care is a field of medicine that focuses on providing relief from symptoms and stress related to serious illnesses. This study will assess the feasibility of conducting a future study, and will gather data upon which to appropriately tailor the intervention and the future study design. The statistical analysis of this study will describe 8 components that encompass each of the 4 areas of focus or "domains": acceptability, demand, implementation, and integration.

Interventions

  • BEHAVIORAL Palliative Care

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-05-16
Est. Completion 2019-06-17
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03471546

The ClinicalTrials.gov registry entry for NCT03471546 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Palliative Care is the first listed.

NCT03471546 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03471546 about?

NCT03471546 is a clinical study titled "Early Palliative Care Intervention in Malignant Glioma". The purpose of this research study is to determine the feasibility and acceptability of incorporating palliative care into the clinical care plans of patients newly diagnosed with malignant brain tumors. Palliative Care is a field of medicine that focuses on providing relief from symptoms and stress...

What is the current status of trial NCT03471546?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-05-16. Estimated completion is 2019-06-17.

What interventions are being tested in trial NCT03471546?

The interventions under investigation include: Palliative Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT03471546?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.